Role of Inflammation and Motility Disorders in the Development, Course and Consequences of Functional Gastrointestinal and Biliary Tract Diseases (Literature Review and Expert Panel Resolution)
Aim: to present the results of the Expert Panel with a discussion of modern concepts of the pathogenesis of functional gastrointestinal diseases and the possibilities of multitarget therapy with trimebutine. Key points. Low-grade inflammation can be considered as a morphological substrate of funct...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2024-10-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/1347 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860072694939648 |
|---|---|
| author | V. T. Ivashkin D. S. Bordin T. L. Lapina M. A. Livzan A. V. Okhlobystin E. A. Poluektova A. S. Trukhmanov Yu. P. Uspenskiy Yu. O. Shulpekova |
| author_facet | V. T. Ivashkin D. S. Bordin T. L. Lapina M. A. Livzan A. V. Okhlobystin E. A. Poluektova A. S. Trukhmanov Yu. P. Uspenskiy Yu. O. Shulpekova |
| author_sort | V. T. Ivashkin |
| collection | DOAJ |
| description | Aim: to present the results of the Expert Panel with a discussion of modern concepts of the pathogenesis of functional gastrointestinal diseases and the possibilities of multitarget therapy with trimebutine. Key points. Low-grade inflammation can be considered as a morphological substrate of functional diseases with an increase in activated mastocytes and eosinophils, T-helpers 2 and T-helpers 17 in the gastrointestinal mucosa. In the development in the content of visceral hypersensitivity, the functional connection between mastocytes and TRPV1-positive sensory endings of the vagus nerve is of great importance. Proinflammatory cytokines and matrix metalloproteinases can enter the systemic circulation, provoking the development of systemic manifestations. Increased levels of proinflammatory cytokines are supported by altered intestinal permeability and microbiota. Functional diseases are believed to modify the symptoms and course of concomitant organic diseases of the gastrointestinal tract (for example, functional diseases of the biliary tract may contribute to the development of cholelithiasis, pancreatitis). The peripheral μ-, κ- and δ-receptor agonist trimebutine (Trimedat®) regulates the production of enterohormones, modulates motility throughout the gastrointestinal tract and normalizes visceral sensitivity. The effectiveness of trimebutine in the treatment of functional disorders has been shown in various studies. Trimebutine helps reduce the production of proinflammatory cytokines, including interleukin-6. Conclusion. In the treatment of functional diseases of the gastrointestinal tract, trimebutine can be considered as a multitarget agent, since the drug helps to normalize motility, reduces the degree of visceral hypersensitivity, exhibits anti-inflammatory and neuroregenerative effects, and can also increase the effectiveness of treatment of concomitant diseases. |
| format | Article |
| id | doaj-art-b4f8a49670c84cf494b3a0b7cc78d4d6 |
| institution | Kabale University |
| issn | 1382-4376 2658-6673 |
| language | Russian |
| publishDate | 2024-10-01 |
| publisher | Gastro LLC |
| record_format | Article |
| series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| spelling | doaj-art-b4f8a49670c84cf494b3a0b7cc78d4d62025-02-10T16:14:40ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732024-10-0134471910.22416/1382-4376-2024-1347-35431035Role of Inflammation and Motility Disorders in the Development, Course and Consequences of Functional Gastrointestinal and Biliary Tract Diseases (Literature Review and Expert Panel Resolution)V. T. Ivashkin0D. S. Bordin1T. L. Lapina2M. A. Livzan3A. V. Okhlobystin4E. A. Poluektova5A. S. Trukhmanov6Yu. P. Uspenskiy7Yu. O. Shulpekova8I.M. Sechenov First Moscow State Medical University (Sechenov University)A.S. Loginov Moscow Clinical Scientific Center; Russian University of Medicine; Tver State Medical UniversityI.M. Sechenov First Moscow State Medical University (Sechenov University)Omsk State Medical UniversityI.M. Sechenov First Moscow State Medical University (Sechenov University)I.M. Sechenov First Moscow State Medical University (Sechenov University)I.M. Sechenov First Moscow State Medical University (Sechenov University)First Saint Petersburg State Medical University named after Academician I.P. Pavlov; Saint Petersburg State Pediatric Medical UniversityI.M. Sechenov First Moscow State Medical University (Sechenov University)Aim: to present the results of the Expert Panel with a discussion of modern concepts of the pathogenesis of functional gastrointestinal diseases and the possibilities of multitarget therapy with trimebutine. Key points. Low-grade inflammation can be considered as a morphological substrate of functional diseases with an increase in activated mastocytes and eosinophils, T-helpers 2 and T-helpers 17 in the gastrointestinal mucosa. In the development in the content of visceral hypersensitivity, the functional connection between mastocytes and TRPV1-positive sensory endings of the vagus nerve is of great importance. Proinflammatory cytokines and matrix metalloproteinases can enter the systemic circulation, provoking the development of systemic manifestations. Increased levels of proinflammatory cytokines are supported by altered intestinal permeability and microbiota. Functional diseases are believed to modify the symptoms and course of concomitant organic diseases of the gastrointestinal tract (for example, functional diseases of the biliary tract may contribute to the development of cholelithiasis, pancreatitis). The peripheral μ-, κ- and δ-receptor agonist trimebutine (Trimedat®) regulates the production of enterohormones, modulates motility throughout the gastrointestinal tract and normalizes visceral sensitivity. The effectiveness of trimebutine in the treatment of functional disorders has been shown in various studies. Trimebutine helps reduce the production of proinflammatory cytokines, including interleukin-6. Conclusion. In the treatment of functional diseases of the gastrointestinal tract, trimebutine can be considered as a multitarget agent, since the drug helps to normalize motility, reduces the degree of visceral hypersensitivity, exhibits anti-inflammatory and neuroregenerative effects, and can also increase the effectiveness of treatment of concomitant diseases.https://www.gastro-j.ru/jour/article/view/1347functional gastrointestinal diseasesfunctional biliary tract diseaseslow-grade inflammationvisceral hypersensitivitymotilitycytokinestrimebutine |
| spellingShingle | V. T. Ivashkin D. S. Bordin T. L. Lapina M. A. Livzan A. V. Okhlobystin E. A. Poluektova A. S. Trukhmanov Yu. P. Uspenskiy Yu. O. Shulpekova Role of Inflammation and Motility Disorders in the Development, Course and Consequences of Functional Gastrointestinal and Biliary Tract Diseases (Literature Review and Expert Panel Resolution) Российский журнал гастроэнтерологии, гепатологии, колопроктологии functional gastrointestinal diseases functional biliary tract diseases low-grade inflammation visceral hypersensitivity motility cytokines trimebutine |
| title | Role of Inflammation and Motility Disorders in the Development, Course and Consequences of Functional Gastrointestinal and Biliary Tract Diseases (Literature Review and Expert Panel Resolution) |
| title_full | Role of Inflammation and Motility Disorders in the Development, Course and Consequences of Functional Gastrointestinal and Biliary Tract Diseases (Literature Review and Expert Panel Resolution) |
| title_fullStr | Role of Inflammation and Motility Disorders in the Development, Course and Consequences of Functional Gastrointestinal and Biliary Tract Diseases (Literature Review and Expert Panel Resolution) |
| title_full_unstemmed | Role of Inflammation and Motility Disorders in the Development, Course and Consequences of Functional Gastrointestinal and Biliary Tract Diseases (Literature Review and Expert Panel Resolution) |
| title_short | Role of Inflammation and Motility Disorders in the Development, Course and Consequences of Functional Gastrointestinal and Biliary Tract Diseases (Literature Review and Expert Panel Resolution) |
| title_sort | role of inflammation and motility disorders in the development course and consequences of functional gastrointestinal and biliary tract diseases literature review and expert panel resolution |
| topic | functional gastrointestinal diseases functional biliary tract diseases low-grade inflammation visceral hypersensitivity motility cytokines trimebutine |
| url | https://www.gastro-j.ru/jour/article/view/1347 |
| work_keys_str_mv | AT vtivashkin roleofinflammationandmotilitydisordersinthedevelopmentcourseandconsequencesoffunctionalgastrointestinalandbiliarytractdiseasesliteraturereviewandexpertpanelresolution AT dsbordin roleofinflammationandmotilitydisordersinthedevelopmentcourseandconsequencesoffunctionalgastrointestinalandbiliarytractdiseasesliteraturereviewandexpertpanelresolution AT tllapina roleofinflammationandmotilitydisordersinthedevelopmentcourseandconsequencesoffunctionalgastrointestinalandbiliarytractdiseasesliteraturereviewandexpertpanelresolution AT malivzan roleofinflammationandmotilitydisordersinthedevelopmentcourseandconsequencesoffunctionalgastrointestinalandbiliarytractdiseasesliteraturereviewandexpertpanelresolution AT avokhlobystin roleofinflammationandmotilitydisordersinthedevelopmentcourseandconsequencesoffunctionalgastrointestinalandbiliarytractdiseasesliteraturereviewandexpertpanelresolution AT eapoluektova roleofinflammationandmotilitydisordersinthedevelopmentcourseandconsequencesoffunctionalgastrointestinalandbiliarytractdiseasesliteraturereviewandexpertpanelresolution AT astrukhmanov roleofinflammationandmotilitydisordersinthedevelopmentcourseandconsequencesoffunctionalgastrointestinalandbiliarytractdiseasesliteraturereviewandexpertpanelresolution AT yupuspenskiy roleofinflammationandmotilitydisordersinthedevelopmentcourseandconsequencesoffunctionalgastrointestinalandbiliarytractdiseasesliteraturereviewandexpertpanelresolution AT yuoshulpekova roleofinflammationandmotilitydisordersinthedevelopmentcourseandconsequencesoffunctionalgastrointestinalandbiliarytractdiseasesliteraturereviewandexpertpanelresolution |